Latest News and Press Releases

MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter,...

New York, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight  According to...

Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024...

Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced topline final data from the APOLLO trial (also known as HPV001).

New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global sexually transmitted disease testing market size is predicted to grow at a CAGR of over ~6% from 2023 to 2035. The market is projected to...

Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Recombinant Vaccines Market generated $8.1 billion in 2021 and is estimated to...

Las Vegas, USA, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight  Human Papillomavirus...

PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by OmniPathology, please note that the second sentence in paragraph one should read "The...

PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus...

Seattle, July 12, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global adult vaccines market is estimated to be valued at US$ 16,790.11 million in 2022 and is expected to...